- Report
- May 2024
- 131 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- June 2024
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- January 2022
- 60 Pages
Global
From €3595EUR$3,950USD£3,082GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- March 2025
- 114 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- March 2025
- 74 Pages
Global
From €3500EUR$4,120USD£3,106GBP
The Enuresis Drug market is a subset of the Urological Disorders Drugs market, which includes medications used to treat a variety of conditions related to the urinary tract. Enuresis Drugs are used to treat bedwetting, a condition in which a person involuntarily urinates while asleep. These drugs are typically prescribed to children and adolescents, although adults may also be prescribed them. Enuresis Drugs work by reducing the amount of urine produced at night, or by increasing the amount of time between urination.
The Enuresis Drug market is highly competitive, with a variety of companies offering different products. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. Other companies in the market include Astellas Pharma, Allergan, and Mylan. Show Less Read more